As of 2025-11-03, the Relative Valuation of Axsome Therapeutics Inc (AXSM) is (99.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 134.99 USD, the upside of Axsome Therapeutics Inc based on Relative Valuation is -173.9%.
The range of the Relative Valuation is (95.10) - (103.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 20.8x | 18.6x |
| Forward P/E multiples | 19.2x - 23.4x | 21.7x |
| Fair Price | (95.10) - (103.11) | (99.70) |
| Upside | -170.4% - -176.4% | -173.9% |
| Date | P/E |
| 2025-10-31 | -27.28 |
| 2025-10-30 | -26.91 |
| 2025-10-29 | -26.95 |
| 2025-10-28 | -26.98 |
| 2025-10-27 | -27.22 |
| 2025-10-24 | -26.18 |
| 2025-10-23 | -25.68 |
| 2025-10-22 | -26.22 |
| 2025-10-21 | -26.55 |
| 2025-10-20 | -26.60 |
| 2025-10-17 | -25.86 |
| 2025-10-16 | -25.26 |
| 2025-10-15 | -26.19 |
| 2025-10-14 | -24.96 |
| 2025-10-13 | -24.49 |
| 2025-10-10 | -24.60 |
| 2025-10-09 | -24.76 |
| 2025-10-08 | -23.99 |
| 2025-10-07 | -23.98 |
| 2025-10-06 | -24.24 |
| 2025-10-03 | -24.31 |
| 2025-10-02 | -24.24 |
| 2025-10-01 | -23.96 |
| 2025-09-30 | -24.55 |
| 2025-09-29 | -23.77 |
| 2025-09-26 | -23.60 |
| 2025-09-25 | -23.45 |
| 2025-09-24 | -24.00 |
| 2025-09-23 | -23.89 |
| 2025-09-22 | -23.75 |
| 2025-09-19 | -23.43 |
| 2025-09-18 | -23.98 |
| 2025-09-17 | -23.57 |
| 2025-09-16 | -23.06 |
| 2025-09-15 | -23.60 |
| 2025-09-12 | -23.93 |
| 2025-09-11 | -24.85 |
| 2025-09-10 | -25.09 |
| 2025-09-09 | -25.40 |
| 2025-09-08 | -26.13 |
| 2025-09-05 | -25.30 |
| 2025-09-04 | -25.14 |
| 2025-09-03 | -24.66 |
| 2025-09-02 | -24.95 |
| 2025-08-29 | -24.51 |
| 2025-08-28 | -24.61 |
| 2025-08-27 | -24.63 |
| 2025-08-26 | -24.49 |
| 2025-08-25 | -23.51 |
| 2025-08-22 | -23.95 |